In defective drug litigation, the primary party held responsible is typically the drug manufacturer
Individuals across the United States are pursuing Ozempic lawsuits against the drug manufacturer, which claim the drug manufacturer failed to adequately warn users about severe gastrointestinal issues such as stomach paralysis and intestinal obstruction, as well as an increased risk of nonarteritic anterior ischemic optic neuropathy (NAION), a serious eye condition
People often have trouble securing weight loss drug prescriptions due to ongoing worldwide GLP-1 shortages
No matter what happens, give yourself grace, Adair emphasizes
Bull World Health Organ 99(4):242 Chattaraj A, Syed MP, Low CA, Owonikoko TK (2023) Cisplatin-Induced Ototoxicity: a concise review of the burden, prevention, and interception strategies